Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors
Shapoval O. S., Vorontsova L. L. Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors = Патогенетическое обоснование применения иммуномодулирующей и системной энзимотерапии в комплексном лечении нерожавш...
Saved in:
Main Authors: | O S Shapoval (Author), L L Vorontsova (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors
by: O S Shapoval, et al.
Published: (2015) -
State of cellular and humoral immune system in women of reproductive age with tumor-like ovary formations
by: O. S. Shapoval, et al.
Published: (2014) -
Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
by: Shuang-zheng Jia, et al.
Published: (2018) -
Sclerosing stromal tumor of the ovary associated with benign endometrioid peritoneal implants
by: Gulati Anchana, et al.
Published: (2009) -
Pathogenetic Rationale for the Use of Probiotics in Antibiotic-Associated Diarrhea in Children
by: O.Ye. Chernysheva
Published: (2015)